These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2956371

  • 1. Changes in left ventricular anatomy and systemic hemodynamics induced by antihypertensive therapy with indenolol.
    De Luca N, Ricciardelli B, Groothold G, Cuocolo A, Volpe M, Trimarco B.
    J Clin Hypertens; 1987 Jun; 3(2):125-34. PubMed ID: 2956371
    [Abstract] [Full Text] [Related]

  • 2. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
    Sau F, Seguro C, Lai C, Orani E, Soro A, Onnis E, Cherchi A.
    Cardiologia; 1990 Nov; 35(11):925-30. PubMed ID: 2151570
    [Abstract] [Full Text] [Related]

  • 3. Computerized echocardiographic study of left ventricular function and cardiodynamic investigation with a new antihypertensive agent (indenolol).
    Venco A, Groothold G, Grandi A, Barzizza F, Corradi L, Negri F, Finardi G.
    Clin Ther; 1985 Nov; 7(3):347-56. PubMed ID: 3995529
    [Abstract] [Full Text] [Related]

  • 4. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
    Trimarco B, Lembo G, DeLuca N, Ricciardelli B, Rosiello G, Volpe M, Orofino G, Condorelli M.
    J Int Med Res; 1988 Nov; 16 Suppl 1():62A-72A. PubMed ID: 2906018
    [Abstract] [Full Text] [Related]

  • 5. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
    Zilcher H, Glogar D, Uhlir H, Leisch F, Niederberger M, Steinbach K.
    Wien Klin Wochenschr; 1978 Sep 01; 90(16):611-6. PubMed ID: 695651
    [Abstract] [Full Text] [Related]

  • 6. [Left ventricular function in essential hypertension during isoproterenol infusion].
    Yasuda M, Oku H, Hirota K, Kajino H, Nishikimi T, Kawarabayashi T, Murai K, Yoshimura T, Takeuchi K, Takeda T.
    J Cardiogr; 1985 Sep 01; 15(3):761-71. PubMed ID: 2942608
    [Abstract] [Full Text] [Related]

  • 7. Correlation between peripheral hemodynamic changes and left ventricular diastolic function in hypertensive patients treated with urapidil.
    Arosio E, Pancera P, Sheiban I, Priante F, Ribul M, De Marchi S, Tonni S, Lechi A.
    J Hum Hypertens; 1996 Mar 01; 10(3):171-6. PubMed ID: 8733035
    [Abstract] [Full Text] [Related]

  • 8. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
    Corea L, Bentivoglio M, Verdecchia P, Provvidenza M, Motolese M.
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul 01; 22(7):365-70. PubMed ID: 6236155
    [Abstract] [Full Text] [Related]

  • 9. Indenolol: a new antihypertensive agent: efficacy, toxicity, and hemodynamic effects in a crossover double-blind study with metoprolol.
    Trimarco B, Cuocolo A, Groothold G, Ricciardelli B, De Luca N, Volpe M, Veniero AM, Condorelli M.
    J Clin Pharmacol; 1985 Jul 01; 25(5):328-36. PubMed ID: 4031109
    [Abstract] [Full Text] [Related]

  • 10. Reversal of left ventricular hypertrophy by terazosin in hypertensive patients.
    Yasumoto K, Takata M, Yoshida K, Mikawa M, Tomoda F, Sasayama S.
    J Hum Hypertens; 1990 Feb 01; 4(1):13-8. PubMed ID: 1971654
    [Abstract] [Full Text] [Related]

  • 11. [Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
    Sau F, Seguro C, Pargentino E.
    Cardiologia; 1994 Jul 01; 39(7):473-9. PubMed ID: 7982244
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular adaptation to cyclosporine-induced hypertension.
    Ventura HO, Lavie CJ, Messerli FH, Valentino V, Smart FW, Stapleton DD, Ochsner JL.
    J Hum Hypertens; 1994 Apr 01; 8(4):233-7. PubMed ID: 8021902
    [Abstract] [Full Text] [Related]

  • 13. Systemic and renal effects of enalapril and its effects on cardiac mass.
    Dunn FG, Oigman W, Ventura HO, Messerli FH, Kobrin I, Frohlich ED.
    J Hypertens Suppl; 1984 Dec 01; 2(2):S57-61. PubMed ID: 6100878
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
    Poggesi L, Bisi G, La Cava G, Sciagra R, Del Rosso A, Masotti G.
    J Clin Pharmacol; 1995 Feb 01; 35(2):176-81. PubMed ID: 7751429
    [Abstract] [Full Text] [Related]

  • 16. Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension.
    Trimarco B, Ricciardelli B, De Luca N, Volpe M, Veniero A, Cuocolo A, Condorelli M.
    Am J Cardiol; 1984 Mar 01; 53(6):791-6. PubMed ID: 6230921
    [Abstract] [Full Text] [Related]

  • 17. Cardiac effects of ACE inhibition.
    Lund-Johansen P, Omvik P.
    J Cardiovasc Pharmacol; 1993 Mar 01; 22 Suppl 1():S36-40. PubMed ID: 7507538
    [Abstract] [Full Text] [Related]

  • 18. Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.
    Malacco E, Mailland F, Bosisio E, Meroni R, Dagani R, Renesto E, Bevilacqua M.
    Eur J Clin Pharmacol; 1986 Mar 01; 30(2):157-60. PubMed ID: 3709639
    [Abstract] [Full Text] [Related]

  • 19. Effects of ACE inhibition on left ventricular dimensions and haemodynamics in systemic hypertension: a radionuclide and echocardiographic study.
    Haznedaroglu IC, Erdem Y, Tokgözoglu L, Caglar M, Kes S, Sayinalp NM, Yörükan S.
    Cent Afr J Med; 1995 Apr 01; 41(4):118-23. PubMed ID: 7788682
    [Abstract] [Full Text] [Related]

  • 20. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI, Hussain M, Forsyth D, Wilson J, Silke B, Taylor SH.
    J Cardiovasc Pharmacol; 1984 Apr 01; 6(1):176-81. PubMed ID: 6199601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.